Stock Earnings

Question 1

Roche Holding AGの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Roche Holding AGの総資産は$101,801で、純profitは$8,277です。

Question 2

RHHVFの主要な財務比率は何ですか？

Accepted Answer

Roche Holding AGの流動比率は1.45、純利益率は13.68、1株当たり売上高は$75.43です。

Question 3

Roche Holding AGの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Roche Holding AG largest revenue segment is Roche Pharmaceuticals, at a revenue of 43,297,000,000 in the most earnings release.For geography, Switzerland is the primary market for Roche Holding AG, at a revenue of 747,000,000.

Question 4

Roche Holding AGは収益を上げていますか？

Accepted Answer

yes、最新の財務諸表によると、Roche Holding AGの純profitは$8,277です。

Question 5

Roche Holding AGに負債はありますか？

Accepted Answer

yes、Roche Holding AGの負債は70,034です。

Question 6

Roche Holding AGの発行済株式数は何株ですか？

Accepted Answer

Roche Holding AGの総発行済株式数は795.4株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	61,591	60,495	58,716	63,281	62,801	58,323
Revenue Growth (YoY)	5%	3%	-7%	1%	8%	-5%
Cost of Revenue	16,060	15,783	15,626	18,630	19,348	15,900
Gross Profit	45,531	44,712	43,090	44,651	43,453	42,423
Selling, General & Admin	13,890	13,758	13,518	12,130	12,100	12,075
Research & Development	--	13,042	13,237	14,053	13,707	12,151
Operating Expenses	24,720	24,625	24,561	24,734	24,922	23,454
Other Non Operating Income (Expenses)	-1,413	-172	-189	-109	-80	-115
Pretax Income	13,158	11,793	14,079	16,327	17,398	17,965
Income Tax Expense	2,836	2,606	1,721	2,796	2,463	2,897
Net Income	9,429	8,277	11,498	12,421	13,930	14,295
Net Income Growth	-11%	-28%	-7%	-11%	-3%	6%
Shares Outstanding (Diluted)	803	802	804	808	860	865
Shares Change (YoY)	0%	0%	-1%	-6%	-1%	0%
EPS (Diluted)	11.75	10.32	14.3	15.37	16.2	16.52
EPS Growth	-11%	-28%	-7%	-5%	-2%	6%
Free Cash Flow	13,202	15,085	11,446	13,251	16,427	11,876
Free Cash Flow Per Share	16.44	18.8	14.23	16.39	19.1	13.72
Gross Margin	73.92%	73.91%	73.38%	70.55%	69.19%	72.73%
Operating Margin	33.78%	33.2%	31.55%	31.47%	29.5%	32.52%
Profit Margin	15.3%	13.68%	19.58%	19.62%	22.18%	24.51%
Free Cash Flow Margin	21.43%	24.93%	19.49%	20.93%	26.15%	20.36%
EBITDA	23,544	23,510	21,993	23,761	22,974	23,527
EBITDA Margin	38.22%	38.86%	37.45%	37.54%	36.58%	40.33%
D&A For EBITDA	2,733	3,423	3,464	3,844	4,443	4,558
EBIT	20,811	20,087	18,529	19,917	18,531	18,969
EBIT Margin	33.78%	33.2%	31.55%	31.47%	29.5%	32.52%
Effective Tax Rate	21.55%	22.09%	12.22%	17.12%	14.15%	16.12%

Roche Holding AG (RHHVF) Price

RHHVF Stock Price Chart

RHHVF Income

Follow-Up Questions